Medicine Description plavictonal 75 mg
Plavictonal 75 mg tablets is a medication that acts as an antiplatelet agent by irreversibly inhibiting the P2Y12 subtype of the adenosine diphosphate (ADP) receptor on platelets. This inhibition prevents the activation of the glycoprotein IIb/IIIa complex, crucial for platelet aggregation. By blocking this pathway, Plavictonal effectively reduces platelet aggregation and thrombus formation, thereby minimizing the risk of clot-related conditions such as myocardial infarction and stroke. The antiplatelet effect persists for the lifespan of the platelet, which is approximately 7 to 10 days, highlighting the importance of careful patient management during and after therapy.
Indications and Uses of Plavictonal 75 mg tablets
- Prevention of atherothrombotic events in patients with established peripheral arterial disease.
- Reduction of the risk of myocardial infarction and stroke in individuals with a history of cardiovascular events.
- Management of patients with unstable angina and non-ST elevation myocardial infarction.
- Post-stenting to prevent thrombotic complications following percutaneous coronary interventions.
Side Effects of Plavictonal 75 mg tablets
- Bleeding complications, including gastrointestinal and intracranial hemorrhage.
- Gastrointestinal disturbances such as nausea and diarrhea.
- Allergic reactions, including rash and pruritus.
- Thrombotic thrombocytopenic purpura (TTP), a rare but serious condition.
Storage and Handling
Store Plavictonal 75 mg tablets at room temperature, away from direct sunlight and moisture. Keep out of reach of children and pets. Ensure that the medication is in its original packaging until use to maintain efficacy.
Patient Advice and Precautions
Patients should be counseled to inform their healthcare provider of all medications and supplements they are taking, as several drugs may interact with Plavictonal. Regular monitoring for signs of bleeding is essential, and patients should avoid activities that may increase the risk of injury. It is crucial to adhere to the prescribed therapy and consult a healthcare professional prior to discontinuing the medication to mitigate the risk of thrombotic events.